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791Abstracts
Psoriasis Area Severity Index (PASI) was calculated at
each time. Health related quality of life forms SF-12 and
Psoriasis Disability Index (PDI) were completed at the
inclusion and ﬁnal visits. RESULTS: Seven hundred
thirty-one patients out of 1286 were included to perform
quality of life analysis. (54.67% men and 45.33%
women). Mean age was 43.59 ± 15.48 years and BMI
25.07 ± 3.84. Mean affected area at inclusion was
15.97% ± 8.14. Basal PDI was 29.20 ± 14.30. Bigger
values for PDI, and therefore worse quality of life, were
registered in patients with PASI values between 10–50
(28.06 ± 15.26) vs. those whose PASI values were below
10 (34.18 ± 13.60 p < 0.001). After 2 months of treat-
ment, most of patients improved their quality life index:
85.20% for PDI, 51.78% for SF-12 physical domains and
83.30% for SF-12 psychical domains. CONCLUSIONS:
Tacalcitol treatment has a positive effect on health related
well-being, improving quality of life measured by unspe-
ciﬁc scales and also by dermatologic indexes such as PDI.
Tacalcitol treatment increases SF-12 scores, especially
those for psychical domains, resulting in improvement on
patients self-esteem.
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OBJECTIVES: A common problem in outcomes research
is translation of enhanced tolerability or convenience to
higher compliance and better effectiveness. This is par-
ticularly tricky for chronic illnesses where time-dependent
factors act in tandem. The objective was to develop an
approach to this problem for administrative database
analyses. METHODS: Data on women with osteoporo-
sis who received medication (1996–2001) were obtained
from Saskatchewan Health. Using dispensing records,
each subject’s compliance pattern was derived; hospital-
ization/physician service records were used to determine
fracture occurrence. Patients were highly compliant if dis-
pensings covered a minimum portion (e.g., 80%) of their
follow-up time. RESULTS: The common approach is to
compare event rates among compliance categories, using
Cox regression to adjust for confounders and relaxing the
assumption of constant rates. Our rates were 8.3% and
11.1% for high and low compliance, respectively (RR =
0.75); the effect estimated from a Cox regression was RR
= 1.24, and RR = 1.29 when adjusted for confounders,
suggesting a detrimental effect for increased compliance.
This analysis is inherently biased, however, since the
timing of compliance measurements in the risk sets of the
Cox model are not concurrent; the compliance of the sur-
vivors in the risk set is deﬁned over a longer period and
so is prone to be lower than the compliance of the subject
who suffered the fracture. Thus, poor compliance
becomes correlated with longer survival and produces
contradictory ﬁndings. This can be resolved by measur-
ing compliance based on medication use only up to the
time of the fracture for all members of a given risk set.
This analysis produced a crude RR = 0.81, and 0.84 when
controlling for other risk factors. CONCLUSIONS: It is
feasible to obtain population-based estimates of the
impact of compliance on outcomes using an administra-
tive database, but the analysis techniques should properly
account for the time dependencies of all pertinent 
variables.
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OBJECTIVES: Residual disability after stroke presents a
major economic and humanistic burden. To quantify dis-
ability in patient, three disability instruments are globally
used: the Barthel Index (BI), Motor component of Func-
tional Independence Measure (M-FIM), and Modiﬁed
Rankin Scale (MRS). Study objectives are: 1) to develop
a crosswalk among these measures by categorizing scores
presenting clinical signiﬁcance; and 2) to examine the
variation of the categorization scheme over time from
stroke onset. METHODS: The Kansas City Stroke Study
(KCSS) data was utilized for the current study. Disability
measures at baseline (stroke index date), one, three and
six month after index date were collected by trained clin-
icians. Polytomous logistic regression analysis was
applied to produce probabilistic distributions of BI or M-
FIM scores, representing clinically distinct disability
states, which were deﬁned by the six levels of the MRS.
Model ﬁt statistics were examined to verify logistic model
appropriateness. A categorization scheme, which mini-
mized the false positive response rate, was selected as the
optimal categorizing system. RESULTS: BI and M-FIM
differentiated disability well in lower ADLs than higher
ADLs. For BI, 4 clinically distinct disability levels were
differentiated with the following categorization scheme:
0 £ MRS5 < 15, 15 £ MRS4 < 70, 70 £ MRS3 < 95, and
95 £ MRS(0 + 1 + 2) £100. For the M-FIM, 3 stages were
